Exploratory randomised controlled clinical study to evaluate the comparative efficacy of two occluding toothpastes - a 5% calcium sodium phosphosilicate toothpaste and an 8% arginine/calcium carbonate toothpaste - for the longer-term relief of dentine hypersensitivity
Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved..
OBJECTIVE: To compare the longer-term clinical efficacy of two occlusion-technology toothpastes - a 5% calcium sodium phosphosilicate (CSPS) toothpaste and a commercially available 8% arginine/calcium carbonate toothpaste - in relieving dentine hypersensitivity (DH). Efficacy was also compared with that of a regular fluoride toothpaste control.
METHODS: This was an exploratory, randomised, examiner-blind, parallel-group, 11-week, controlled study in healthy adults with self-reported and clinically diagnosed DH. After an acclimatisation period, subjects were randomised to one of three study treatments with which they brushed their teeth twice daily. Sensitivity was assessed at baseline and after 1, 2, 4, 6 and 11 weeks treatment in response to evaporative (air) and tactile stimuli (measured by the Schiff Sensitivity Scale/visual analogue scale and tactile threshold, respectively).
RESULTS: A total of 135 subjects were randomised to treatment. The two occlusion-technology toothpastes performed similarly over the 11-week treatment period. All study treatments showed statistically significant reductions from baseline in DH at all timepoints for all measures (p<0.05). Statistically significant and clinically relevant sensitivity relief was observed for both occluding formulations compared with the regular fluoride toothpaste: for evaporative (air) sensitivity within 1 week and for tactile sensitivity at Week 11. No significant differences were detected between the two occluding formulations at any timepoint, for any endpoint. Study treatments were generally well tolerated.
CONCLUSIONS: In this exploratory study, a 5% CSPS occluding toothpaste was effective in relieving DH compared with a regular fluoride toothpaste; an 8% arginine/calcium carbonate anti-sensitivity toothpaste provided similar benefits. Improvements in DH continued throughout the 11-week study.
CLINICAL SIGNIFICANCE: Dentine hypersensitivity (DH) is a common and painful condition. Twice-daily use of a 5% calcium sodium phosphosilicate toothpaste reduces DH within 1-2 weeks of initiating use. Ongoing, twice daily use of the sensitivity toothpastes evaluated in this study was associated with continued, clinically significant improvements in DH.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2017 |
---|---|
Erschienen: |
2017 |
Enthalten in: |
Zur Gesamtaufnahme - volume:60 |
---|---|
Enthalten in: |
Journal of dentistry - 60(2017) vom: 28. Mai, Seite 36-43 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Hall, Claire [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 03.05.2018 Date Revised 16.03.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.jdent.2017.02.009 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM269141456 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM269141456 | ||
003 | DE-627 | ||
005 | 20240316232348.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2017 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.jdent.2017.02.009 |2 doi | |
028 | 5 | 2 | |a pubmed24n1332.xml |
035 | |a (DE-627)NLM269141456 | ||
035 | |a (NLM)28219674 | ||
035 | |a (PII)S0300-5712(17)30037-4 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Hall, Claire |e verfasserin |4 aut | |
245 | 1 | 0 | |a Exploratory randomised controlled clinical study to evaluate the comparative efficacy of two occluding toothpastes - a 5% calcium sodium phosphosilicate toothpaste and an 8% arginine/calcium carbonate toothpaste - for the longer-term relief of dentine hypersensitivity |
264 | 1 | |c 2017 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 03.05.2018 | ||
500 | |a Date Revised 16.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved. | ||
520 | |a OBJECTIVE: To compare the longer-term clinical efficacy of two occlusion-technology toothpastes - a 5% calcium sodium phosphosilicate (CSPS) toothpaste and a commercially available 8% arginine/calcium carbonate toothpaste - in relieving dentine hypersensitivity (DH). Efficacy was also compared with that of a regular fluoride toothpaste control | ||
520 | |a METHODS: This was an exploratory, randomised, examiner-blind, parallel-group, 11-week, controlled study in healthy adults with self-reported and clinically diagnosed DH. After an acclimatisation period, subjects were randomised to one of three study treatments with which they brushed their teeth twice daily. Sensitivity was assessed at baseline and after 1, 2, 4, 6 and 11 weeks treatment in response to evaporative (air) and tactile stimuli (measured by the Schiff Sensitivity Scale/visual analogue scale and tactile threshold, respectively) | ||
520 | |a RESULTS: A total of 135 subjects were randomised to treatment. The two occlusion-technology toothpastes performed similarly over the 11-week treatment period. All study treatments showed statistically significant reductions from baseline in DH at all timepoints for all measures (p<0.05). Statistically significant and clinically relevant sensitivity relief was observed for both occluding formulations compared with the regular fluoride toothpaste: for evaporative (air) sensitivity within 1 week and for tactile sensitivity at Week 11. No significant differences were detected between the two occluding formulations at any timepoint, for any endpoint. Study treatments were generally well tolerated | ||
520 | |a CONCLUSIONS: In this exploratory study, a 5% CSPS occluding toothpaste was effective in relieving DH compared with a regular fluoride toothpaste; an 8% arginine/calcium carbonate anti-sensitivity toothpaste provided similar benefits. Improvements in DH continued throughout the 11-week study | ||
520 | |a CLINICAL SIGNIFICANCE: Dentine hypersensitivity (DH) is a common and painful condition. Twice-daily use of a 5% calcium sodium phosphosilicate toothpaste reduces DH within 1-2 weeks of initiating use. Ongoing, twice daily use of the sensitivity toothpastes evaluated in this study was associated with continued, clinically significant improvements in DH | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Randomized Controlled Trial | |
650 | 4 | |a Calcium sodium phosphosilicate | |
650 | 4 | |a Dentine hypersensitivity | |
650 | 4 | |a Occlusion | |
650 | 4 | |a Toothpaste | |
650 | 7 | |a Calcium Phosphates |2 NLM | |
650 | 7 | |a Dentin Desensitizing Agents |2 NLM | |
650 | 7 | |a Silicates |2 NLM | |
650 | 7 | |a Toothpastes |2 NLM | |
650 | 7 | |a rhenanite |2 NLM | |
650 | 7 | |a 7850XT8YDT |2 NLM | |
650 | 7 | |a Sodium Fluoride |2 NLM | |
650 | 7 | |a 8ZYQ1474W7 |2 NLM | |
650 | 7 | |a Arginine |2 NLM | |
650 | 7 | |a 94ZLA3W45F |2 NLM | |
650 | 7 | |a Calcium Carbonate |2 NLM | |
650 | 7 | |a H0G9379FGK |2 NLM | |
650 | 7 | |a Fluorides |2 NLM | |
650 | 7 | |a Q80VPU408O |2 NLM | |
700 | 1 | |a Mason, Stephen |e verfasserin |4 aut | |
700 | 1 | |a Cooke, Jonathan |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of dentistry |d 1972 |g 60(2017) vom: 28. Mai, Seite 36-43 |w (DE-627)NLM000213578 |x 1879-176X |7 nnns |
773 | 1 | 8 | |g volume:60 |g year:2017 |g day:28 |g month:05 |g pages:36-43 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jdent.2017.02.009 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 60 |j 2017 |b 28 |c 05 |h 36-43 |